As we sit here the professors hsv 2 vaccine is attacking the virus as it lays dormant in the pools. The 58% reduction in viral shedding will increase dramatically over time as expected. With data in hand we will then partner with big pharma and bring this therapeutic vaccine to market. Our big pharma partner will also assist us to rapidly increase the sales of CC and VC adapt products via their established pipelines and sales networks in accordance with the agreement we negotiate with them. Prices will be up and we will all live happy ever after.
Ann: Appendix 4C - quarterly, page-228
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73 | $18.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.33 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |